JM Invests in Additional Capacity to Meet Market Demand for Microfiber

Global manufacturer and marketer of energy-efficient products for building insulation, as well as specialty engineered materials, Johns Manville will address the growing demand for Microfiber by adding capacity. To achieve this, the company plans to restart the previously closed capacity in Ohio.

The additional capacity will be located outside JM’s Waterville, Ohio-based plant. The new assets of the facility will boost few products supply by 35%. Absorptive glass mat battery separators and high efficiency air filtration are key markets for Microfiber.

The company makes investment in the additional capacity to serve customers’ requirements. One of the JM’s executives, J.P. Blanchard quotes that the company has been serving the customer needs for more than 150 years. Bob Wamboldt, VP of Engineered Products North America, said that Johns Manville owns considerable resources to expand the Microfiber business. He also said that it was the right time for investing in additional capacity, thereby meeting market demand and customer needs. The company is committed to support global operations of their customers and to grow along with them.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 09). JM Invests in Additional Capacity to Meet Market Demand for Microfiber. AZoM. Retrieved on November 22, 2024 from https://www.azom.com/news.aspx?newsID=28427.

  • MLA

    Chai, Cameron. "JM Invests in Additional Capacity to Meet Market Demand for Microfiber". AZoM. 22 November 2024. <https://www.azom.com/news.aspx?newsID=28427>.

  • Chicago

    Chai, Cameron. "JM Invests in Additional Capacity to Meet Market Demand for Microfiber". AZoM. https://www.azom.com/news.aspx?newsID=28427. (accessed November 22, 2024).

  • Harvard

    Chai, Cameron. 2019. JM Invests in Additional Capacity to Meet Market Demand for Microfiber. AZoM, viewed 22 November 2024, https://www.azom.com/news.aspx?newsID=28427.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.